Background and Aims: Ultrasound-guided ilioinguinal–iliohypogastric nerve block (II–IHNB) provides effective analgesia for inguinal hernia surgery; however, the duration of analgesia with local anaesthetic alone is limited. This study compared dexmedetomidine and magnesium sulphate as adjuvants to ropivacaine for II–IHNB. Methods: In this randomised controlled trial, 120 patients were allocated into three groups ( n = 40 each). Group A received 0.5% ropivacaine, group B received ropivacaine with magnesium sulphate (5 mg/kg), and group C received ropivacaine with dexmedetomidine (1 µg/kg). The primary outcome was time to first rescue analgesia. Secondary outcomes included visual analogue scale (VAS) scores, 24-hour opioid consumption, sedation, haemodynamic parameters, and adverse events. Results: The time to first rescue analgesia was significantly longer in group C than in group A, with a median difference of 1080 min [95% confidence interval (CI): 923–1125 min; P < 0.001]. The total 24-hour opioid consumption was significantly lower in group C than in group A, with a median difference of − 10 morphine milligram equivalents (95% CI: −15 to − 5; P < 0.001). VAS scores at rest and movement were significantly lower in group C at multiple postoperative time points ( P < 0.001). Sedation scores were higher in group C in the immediate postoperative period ( P < 0.001), but no clinically significant respiratory depression occurred. Haemodynamic parameters and the incidence of adverse events remained comparable across groups ( P > 0.05). Conclusion: Dexmedetomidine is superior to magnesium sulphate as an adjuvant to ropivacaine in II–IHNB, providing prolonged analgesia, reduced opioid consumption, and stable haemodynamics with an acceptable sedation profile.
15 January 2025 in Indian Journal of Clinical Anaesthesia
: Laryngoscopy and intubation cause augmented sympathoadrenal activity leading to hemodynamic alterations elicited by tachycardia and hypertension. Various drugs have been tried by multiple routes to attenuate the stress response, but none of them proved to be ideal. Dexmedetomidine nebulization at 1 mcg/kg used for negating this stress response resulted in a considerable drop in heart rate (HR) and blood pressure after induction of anesthesia. Hence, we intended to use dexmedetomidine at a lower dose and compare its efficacy with the conventional dose of 1mcg/kg in providing stable hemodynamics.: 100 patients scheduled for elective surgeries under general endotracheal anesthesia were randomized into group DA [received pre-operative dexmedetomidine nebulization at a dose of 1 mcg/kg] and group DB [received preoperative dexmedetomidine nebulization at a dose of 0.75 mcg/kg]. The HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were recorded before nebulization, after nebulization, and at 1-, 3-, 5-, and 10-minute post‑intubation. The induction dose of propofol, incidence of postoperative nausea and vomiting (PONV), and sore throat were also noted.A statistically significant reduction was seen in SBP after nebulization (p= 0.030) and at 10 minutes post-intubation (p=0.006) in group DA compared to group DB. DBP in group DA was decreased significantly post-nebulization (p=0.001) at one-minute post-intubation (p=0.014), at three minutes post-intubation (p=0.028), and after ten minutes post-intubation (<p=0.001). Group DA showed a significantly lower MAP compared to group DB after nebulization (p=0.003), one-minute post-intubation(p=0.040), and ten minutes after intubation (<p=0.001). No statistically significant difference was seen in the attenuation of HR, reduction of induction dose of propofol, and reduction in the incidence of PONV between the two groups. Nebulized dexmedetomidine at a dose of 0.75 µg/kg effectively diminishes the stress response to laryngoscopy and intubation with better hemodynamic stability than the conventional dose of 1 µg/kg.
17 September 2026 in Indian Journal of Anaesthesia